Voyager Biomedical is committed to improving the lives of dialysis patients through the development of a novel vascular access device.
Voyager Biomedical has raised $5.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Voyager Biomedical's investors include MedTech Innovator, Texas A&M Innovation.
Voyager Biomedical is headquartered in College Station, United States.
Voyager Biomedical is committed to improving the lives of dialysis patients through the development of a novel vascular access device.
Voyager Biomedical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Voyager Biomedical — Funding & Investors." VCBacked, April 4, 2025, https://www.vcbacked.co/company/voyager-biomedical. Accessed July 23, 2026.
VCBacked. (2025). Voyager Biomedical — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/voyager-biomedical
{{cite web |title=Voyager Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/voyager-biomedical |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated